中东和非洲新生儿黄疸管理市场 – 行业趋势和 2028 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

中东和非洲新生儿黄疸管理市场 – 行业趋势和 2028 年预测

  • Medical Devices
  • Published Report
  • Mar 2021
  • MEA
  • 350 页面
  • 桌子數: 94
  • 图号: 43

>中东和非洲新生儿黄疸管理市场,按管理(诊断、治疗)、类型(初级保健、二级保健)、技术(发光二极管光源、荧光、卤素、光纤、其他)、最终用户(医院、诊所、门诊手术中心、家庭用户、其他)、分销渠道(直接招标、零售、第三方分销)、国家(沙特阿拉伯、南非、阿联酋、以色列、埃及和中东及非洲其他地区)划分的行业趋势和预测到 2028 年

中东和非洲新生儿黄疸管理市场市场分析和洞察:中东和非洲新生儿黄疸管理市场

新生儿黄疸管理市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析,在 2021 年至 2028 年的预测期内,该市场以 5.3% 的复合年增长率增长,预计到 2028 年将达到 1861 万美元。新生儿黄疸患者数量的增加以及疾病检测和治疗技术的进步是推动预测期内新生儿黄疸管理市场需求的主要驱动力。

黄疸一词源于法语单词“jaune”,意为黄色。新生儿黄疸的特征是皮肤和眼睛(巩膜和结膜)呈现黄色。它是新生儿最常见的疾病之一,发生在出生后的第一周。它主要发生在 60% 的足月儿和 80% 的早产儿中。

早产数量增加,尤其是在中东和非洲地区,需要额外的黄疸治疗,这些婴儿必须在医生的护理下住院,并应每天接受监测,这可能会增加新生儿黄疸管理市场的增长。新生儿黄疸管理治疗和诊断的采用率较低,尤其是在低收入国家,可能会成为新生儿黄疸管理市场增长的制约因素。医疗保健支出的增加可以促进技术进步和治疗选择的增加,这可能为新生儿黄疸管理市场的增长提供机会。与新生儿黄疸相关的并发症是患者群体以及新生儿黄疸管理市场研究人员和医生面临的挑战因素。

新生儿黄疸管理市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息,分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和新生儿黄疸管理市场情景,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您创建收入影响解决方案以实现您的预​​期目标。

中东和非洲新生儿黄疸管理市场中东和非洲新生儿黄疸管理市场范围和市场规模

新生儿黄疸管理市场根据管理、类型、技术、最终用户和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

  • 根据管理,新生儿黄疸管理市场细分为治疗和诊断。 2021 年,由于新生儿黄疸患病率上升,且新生儿黄疸诊断对每个孩子都是强制性的,因此诊断部分预计将在新生儿黄疸管理市场中占据主导地位。
  • 根据类型,新生儿黄疸管理市场分为初级保健和二级保健。2021 年,初级保健领域预计将主导新生儿黄疸管理市场,因为初级保健是患有黄疸的新生儿护理的常见和初始标准。
  • 根据技术,新生儿黄疸管理市场细分为荧光、卤素、光纤、发光二极管光源和其他。 2021 年,发光二极管光源部分预计将主导新生儿黄疸管理市场,因为大多数医疗机构都拥有基于 LED 的产品,而且这些产品非常有效。
  • 根据最终用户,新生儿黄疸管理市场分为医院、诊所、门诊手术中心、家庭用户和其他。2021 年,医院部门在新生儿黄疸管理市场中占据主导地位,因为医院拥有高度专业的专业人员和治疗新生儿黄疸的先进技术。
  • 根据分销渠道,新生儿黄疸管理市场分为直接招标、零售和第三方分销。2021 年,直接招标市场预计将主导新生儿黄疸管理市场,因为光疗设备或设备价格昂贵,购买设备时需要进行多家供应商分析。

新生儿黄疸管理市场国家级分析

对新生儿黄疸管理市场进行了分析,并按上述国家、管理、类型、技术、最终用户和分销渠道提供了市场规模信息。

中东和非洲新生儿黄疸管理市场报告涉及的国家包括沙特阿拉伯、南非、阿联酋、以色列、埃及和中东和非洲其他地区。

由于新生儿黄疸患病率上升,预计中东和非洲地区的诊断部门将在 2021 年至 2028 年预测期内以最高增长率增长。南非引领中东和非洲市场的增长,诊断部门在该地区占据主导地位,这要归功于政府为提高孕妇的认识而采取的举措。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。

技术进步和有效的光疗法正在推动新生儿黄疸管理市场的增长

新生儿黄疸管理市场还为您提供每个国家新生儿黄疸管理行业增长的详细市场分析,包括新生儿黄疸管理药物销售、新生儿黄疸管理技术进步的影响以及监管环境的变化及其对新生儿黄疸管理市场的支持。数据涵盖 2010 年至 2019 年的历史时期。

竞争格局和新生儿黄疸管理市场份额分析

新生儿黄疸管理市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对新生儿黄疸管理市场的关注有关。

从事新生儿黄疸管理的主要公司有 Atom Medical Corp.、avihealthcare、Ibis Medical、Natus Medical Incorporated.、DAVID、Signify Holding.、Weyer GmbH、nice Neotech Medical Systems Pvt. Ltd.、Phoenix Medical Systems (P) Ltd、Aeroflow, Inc.、郑州迪森仪器和仪表有限公司、GENERAL ELECTRIC COMPANY、Neolight、Ardo、NeoMedLight、SS TECHNOMED(P)LTD、Drägerwerk AG & Co. KGaA、Braun & Co. Limited、HERBERT WALDMANN GMBH & CO. KG、GINEVRI srl、Shvabe Zurich GmbH 等等。

全球各地的公司也纷纷推出新产品并签署协议,这也加速了新生儿黄疸管理市场的发展。

例如,

  • 2019 年 7 月,Atom Medical Corp. 宣布该公司已吸收合并其子公司 ATOM Medical International, Inc. (AMI)。AMI 现在将成为 Atom Medical Corp 的部门,业务将由该公司继续开展。这有助于该公司增加市场份额并在全球范围内拓展业务。
  • 2020 年 1 月,nice Nanotech Medical Systems Pvt. Ltd. 宣布扩大其新生儿产品范围,原因是国内和国际市场都取得了积极成果。该公司考虑了合作,以扩大产品的推广。此次扩张有助于公司开拓市场并扩大业务,从而增加产品在全球的市场销量。

市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在新生儿黄疸管理市场中的市场,这也为组织改善其在新生儿黄疸管理方面的服务提供了好处。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 MANAGEMENT LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET MANAGEMENT COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: LAWS AND REGULATIONS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISING PATIENT POPULATION SUFFERING FROM NEONATAL JAUNDICE

5.1.2 LARGE NUMBER OF RISK FACTORS

5.1.3 RISING NUMBER OF NEW-BORN INFANTS

5.1.4 INCREASE IN PRETERM BIRTH

5.1.5 AWARENESS ABOUT NEONATAL JAUNDICE AMONG THE POPULATION

5.2 RESTRAINTS

5.2.1 SIDE-EFFECTS RELATED TO PHOTOTHERAPY

5.2.2 PRODUCT RECALLS

5.2.3 LIMITED ADOPTION OF NEONATAL JAUNDICE MANAGEMENT

5.3 OPPORTUNITIES

5.3.1 INCREASING HEALTHCARE EXPENDITURE

5.3.2 TECHNOLOGICAL ADVANCEMENT IN DIAGNOSIS AND TREATMENT

5.3.3 INCREASING DISPOSABLE INCOME

5.3.4 INCREASE IN AGREEMENTS AND ACQUISITIONS

5.4 CHALLENGES

5.4.1 COMPLICATIONS RELATED TO NEONATAL JAUNDICE

5.4.2 LACK OF SKILLED PROFESSIONALS

5.4.3 DIAGNOSIS OF NEONATAL JAUNDICE

6 COVID-19 IMPACT ON MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET IN HEALTHCARE INDUSTRY

6.1 PRICE IMPACT

6.2 IMPACT ON DEMAND

6.3 IMPACT ON SUPPLY CHAIN

6.4 STRATEGIC DECISION FOR MANUFACTURERS / SERVICE PROVIDERS

6.5 CONCLUSION

7 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT

7.1 OVERVIEW

7.2 DIAGNOSIS

7.2.1 TRANSCUTANEOUS BILIRUBINOMETER (TCB)

7.2.2 TOTAL SERUM BILIRUBIN (TSB)

7.2.3 VISUAL ASSESSMENT

7.3 TREATMENT

7.3.1 PHOTOTHERAPY

7.3.1.1 LED PHOTOTHERAPY

7.3.1.2 FIBREOPTIC PHOTOTHERAPY

7.3.1.3 CONVENTIONAL PHOTOTHERAPY

7.3.1.3.1 CONVENTIONAL PHOTOTHERAPY WITH COMPACT FLUORESCENT LAMP

7.3.1.3.2 CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP

7.3.1.3.2.1 FULL-BODY PHOTOTHERAPY

7.3.1.3.2.2 PARTIAL-BODY PHOTOTHERAPY

7.3.2 EXCHANGE TRANSFUSION

7.3.3 INTRAVENOUS IMMUNOGLOBULIN

7.3.4 OTHERS

8 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE

8.1 OVERVIEW

8.2 PRIMARY CARE

8.3 SECONDARY CARE

9 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY

9.1 OVERVIEW

9.2 LIGHT-EMITTING DIODE LIGHT SOURCES

9.3 FIBEROPTIC

9.4 FLUORESCENT

9.5 HALOGEN

10 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 CLINICS

10.4 HOME USERS

10.5 AMBULATORY SURGICAL CENTERS

10.6 OTHERS

11 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDERS

11.3 RETAIL SALES

11.4 THIRD PARTY DISTRIBUTION

12 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET BY GEOGRAPHY

12.1 MIDDLE EAST AND AFRICA

12.1.1 SOUTH AFRICA

12.1.2 SAUDI ARABIA

12.1.3 UAE

12.1.4 ISRAEL

12.1.5 EGYPT

12.1.6 REST OF MIDDLE EAST AND AFRICA

13 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

14 SWOT

15 COMPANY PROFILES

15.1 SIGNIFY HOLDING

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE FINANCIALS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY)

15.2.1 COMPANY SNAPSHOT

15.2.2 RECENT FINANCIALS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 ATOM MEDICAL CORP.

15.3.1 COMPANY SNAPSHOT

15.3.2 COMPANY SHARE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENTS

15.4 NATUS MEDICAL INCORPORATED

15.4.1 COMPANY SNAPSHOT

15.4.2 RECENT FINANCIALS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENTS

15.5 DRAGERWERK AG & CO. KGAA

15.5.1 COMPANY SNAPSHOT

15.5.2 RECENT FINANCIALS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENT

15.6 HERBERT WALDMANN GMBH & CO. KG

15.6.1 COMPANY SNAPSHOT

15.6.2 PRODUCT PORTFOLIO

15.6.3 RECENT DEVELOPMENTS

15.7 AEROFLOW, INC.

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENT

15.8 ARDO

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 AVIHEALTHCARE

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENTS

15.1 BRAUN & CO. LIMITED

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 DAVID

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 GINEVRI SRL

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENTS

15.13 IBIS MEDICAL

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENTS

15.14 NEOLIGHT

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENTS

15.15 NEOMEDLIGHT

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENTS

15.16 NICE NANOTECH MEDICAL SYSTEMSPVT. LTD.

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENTS

15.17 PHOENIX MEDICAL SYSTEMS (P) LTD

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENTS

15.18 S S TECHNOMED (P) LTD

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENT

15.19 SHVABE ZURICH GMBH

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENTS

15.2 WEYER GMBH

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENT

15.21 ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

表格列表

LIST OF TABLES

TABLE 1 REGULATION IMPOSED BY SEVERAL REGULATORY AGENCIES IN DIFFERENT REGIONS

TABLE 2 RISK FACTORS FOR NEONATAL JAUNDICE

TABLE 3 CHARACTERISTICS OF TERM AND PRETERM INFANTS

TABLE 4 HEALTHCARE EXPENDITURE IN ASIA

TABLE 5 QUESTIONNAIRE FOR THE ONLINE FOLLOW-UP

TABLE 6 TIME SCHEDULE OF ONLINE FOLLOW-UP AFTER DISCHARGE

TABLE 7 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA PRIMARY CARE IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA SECONDARY CARE IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA LIGHT-EMITTING DIODE LIGHT SOURCES IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA FIBEROPTIC IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA FLUORESCENT IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA HALOGEN IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA HOSPITALS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA CLINICS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA HOME USERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA OTHERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA DIRECT TENDERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, REGION, 2019-2028 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA RETAIL SALES IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTION IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 44 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 45 SOUTH AFRICA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 46 SOUTH AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 47 SOUTH AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 48 SOUTH AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 49 SOUTH AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 50 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 51 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 52 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 54 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 55 SAUDI ARABIA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 56 SAUDI ARABIA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 57 SAUDI ARABIA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 58 SAUDI ARABIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 59 SAUDI ARABIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 60 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 61 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 62 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 63 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 64 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 65 UAE DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 66 UAE TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 67 UAE TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 68 UAE TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 69 UAE TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 70 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 71 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 72 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 73 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 74 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 75 ISRAEL DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 76 ISRAEL TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 77 ISRAEL TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 78 ISRAEL TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 79 ISRAEL TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 80 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 81 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 82 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 83 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 84 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 85 EGYPT DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 86 EGYPT TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 87 EGYPT TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 88 EGYPT TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 89 EGYPT TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 90 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 91 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 92 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 93 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 94 REST OF MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

 

图片列表

LIST OF FIGURES

FIGURE 1 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: MIDDLE EAST AND AFRICA VS. REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: MULTIVARIATE MODELLING

FIGURE 7 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: MARKET MANAGEMENT COVERAGE GRID

FIGURE 11 MIDDLE EAST AND AFRICA BRONCHIECTASIS MARKET: SEGMENTATION

FIGURE 12 RISING PATIENT POPULATION SUFFERING FROM NEONATAL JAUNDICE IS DRIVING THE MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 MANAGEMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET

FIGURE 15 GRAPHICAL REPRESENTATION FOR NUMBER OF CHILDBIRTH ON THE BASIS OF DIFFERENT REGIONS

FIGURE 16 GRAPHICAL REPRESENTATION FOR NUMBER OF PRETERM CHILDBIRTH FOR DIFFERENT COUNTRIES

FIGURE 17 HEALTH SPENDING BY MAJOR NUMBER OF FUNDS

FIGURE 18 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT, 2021

FIGURE 19 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT, 2019-2028 (USD MILLION)

FIGURE 20 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT, CAGR (2021-2028)

FIGURE 21 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT, LIFELINE CURVE

FIGURE 22 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TYPE, 2021

FIGURE 23 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TYPE, 2019-2028 (USD MILLION)

FIGURE 24 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 25 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 26 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TECHNOLOGY, 2021

FIGURE 27 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TECHNOLOGY, 2019-2028 (USD MILLION)

FIGURE 28 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TECHNOLOGY, CAGR (2021-2028)

FIGURE 29 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TECHNOLOGY, LIFELINE CURVE

FIGURE 30 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY END USER, 2021

FIGURE 31 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 32 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY END USER, CAGR (2021-2028)

FIGURE 33 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 34 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 35 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

FIGURE 36 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 37 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 38 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: SNAPSHOT (2020)

FIGURE 39 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY COUNTRY (2020)

FIGURE 40 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 41 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 42 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT (2021-2028)

FIGURE 43 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: COMPANY SHARE 2020 (%)

 

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.